The Université de Sherbrooke’s Institut de pharmacologie de Sherbrooke is leading a consortium of institutions, hospitals, incubators, and other organizations in a $27M project focused on pharmaceuticals. The consortium, called Acuity Quebec, involves over 20 partners, including the Université de Montréal and the Institut national de la recherche scientifique. The three-year project will involve using artificial intelligence, chemistry, molecular imaging, and pharmacology to better predict efficacy and reduce adverse effects of new pharmaceutical molecules.
(QC)USherbrooke
